-+ 0.00%
-+ 0.00%
-+ 0.00%

Q1 Earnings Preview Could Be A Key Test For Amcor Stock

Simply Wall St·10/27/2026 14:14:06
Listen to the news
  • Amcor is set to report Q1 FY2027 results on 4 November after market close, following recent revenue growth, stronger adjusted earnings and early cost synergies from the Berry integration.
  • The early outperformance of Berry related synergies, alongside portfolio reshaping toward higher margin categories, highlights how execution on integration and mix could matter more than headline earnings on the day.
  • The upcoming Q1 results and early Berry integration synergies will help shape Amcor's broader investment narrative.

Scan how Amcor’s integration story compares with other packaging and industrial players by reviewing a curated list of list of solid balance sheet and fundamentals (24 results) in the current market.

Amcor Investment Narrative Recap

To own Amcor, you need to be comfortable with a packaging group that focuses on integration, mix improvement and cash generation, rather than fast top line expansion. The near term story depends on Berry related synergies continuing to show through in earnings quality and margins, alongside stable demand in core nutrition, health and consumer categories.

Right now, the key short term catalyst is evidence that the US$650m three year synergy target remains on track after the initial US$285m in fiscal 2026. The biggest near term risk is that organic volumes stay weak or integration benefits level off, which would make it harder to lift margins while still carrying elevated leverage.

The Berry integration itself is the announcement that ties most closely to this upcoming Q1 report. Management has already booked US$285m of first year benefits toward a US$650m goal over three years, and early comments around revenue synergies suggest more than just cost cutting is in play for Amcor’s packaging platform.

The key question is how quickly that integration progress translates into cleaner cash generation, working capital recovery and debt reduction, given leverage around 3.5x and a dividend that is not fully covered by earnings or free cash flow. Analyst sentiment appears constructive, but the evidence will come from how consistently Amcor turns these early synergy gains into sustained margin and balance sheet improvement.

Analysts expect Amcor's narrative to line up with revenues of $24.2b and earnings of $1.9b by 2029, which would represent about 1.0% yearly revenue growth and an earnings increase of roughly $0.8b from the current $1.1b base.

Uncover why Amcor's fair value indicates a 9% potential upside to its current price that could narrow quickly.

NYSE:AMCR 1-Year Stock Price Chart
NYSE:AMCR 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic Amcor watchers focus on the catalyst of faster Berry revenue synergies. They were pencilling in revenue of about US$25.2b and earnings of roughly US$2.3b by 2029, compared with the consensus US$24.2b and US$1.9b. Use this Q1 update to test which storyline feels closer to your view.

Explore 6 other Amcor fair value estimates, including one that suggests as much as 108% upside from the current price.

The Verdict Is Yours

Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

Looking for more investment ideas beyond Amcor?

Once you have a view on Amcor, it often helps to line it up against other opportunities so you can judge risk, quality and income potential in context.

  • If you want potential mispricing with quality in mind, scan a curated set of 29 high quality undervalued stocks that balance robust fundamentals with appealing valuations.
  • If resilience matters most to you, focus on a 30 resilient stocks with low risk scores that screens for businesses with steadier profiles and fewer red flags.
  • If reliable income is high on your list, check a 5 dividend fortresses that concentrates on higher yielding companies with solid payout track records.